ad

Univest Blogs

Aditya Birla Fashion and Retail Q2 Results FY27: Revenue Down 23.75% YoY to Rs 1,511.04 Cr, Net Loss Rs 180.44 Cr

Aditya Birla Fashion and Retail Q2 Results FY27: Revenue Down 23.75% YoY to Rs 1,511.04 Cr, Net Loss Rs 180.44 Cr


6 November 2026

14 min read

Sonata Software Q2 Results FY27: Revenue Up 15.38% YoY to Rs 2,445.20 Cr, Net Profit Rs 116.40 Cr

Sonata Software Q2 Results FY27: Revenue Up 15.38% YoY to Rs 2,445.20 Cr, Net Profit Rs 116.40 Cr


6 November 2026

12 min read

ad
Tonbo Imaging India Q2 Results FY27: Revenue Rs 183.26 Cr, Net Profit Rs 23.49 Cr Against Loss a Year Ago

Tonbo Imaging India Q2 Results FY27: Revenue Rs 183.26 Cr, Net Profit Rs 23.49 Cr Against Loss a Year Ago


6 November 2026

13 min read

NCC Q2 Results FY27: Revenue Up 8.23% YoY to Rs 4,917.08 Cr, Net Profit Rs 163.17 Cr

NCC Q2 Results FY27: Revenue Up 8.23% YoY to Rs 4,917.08 Cr, Net Profit Rs 163.17 Cr


6 November 2026

12 min read

SYMBIOTEC PHARMALAB Q2 Results FY27: Net Profit Jumps 267.85% QoQ to Rs 51.72 Cr, Revenue Rs 279.93 Cr

SYMBIOTEC PHARMALAB Q2 Results FY27: Net Profit Jumps 267.85% QoQ to Rs 51.72 Cr, Revenue Rs 279.93 Cr


6 November 2026

12 min read

Time Technoplast Q2 Results FY27: Revenue Jumps 31.97% to Rs 1,994.19 Cr, PAT Rs 148.31 Cr

Time Technoplast Q2 Results FY27: Revenue Jumps 31.97% to Rs 1,994.19 Cr, PAT Rs 148.31 Cr


6 November 2026

12 min read

ad
Kingfa Science & Technology Q2 Results FY27: Revenue Jumps 55.27% to Rs 723.08 Cr, PAT Rs 47.03 Cr

Kingfa Science & Technology Q2 Results FY27: Revenue Jumps 55.27% to Rs 723.08 Cr, PAT Rs 47.03 Cr


6 November 2026

13 min read

VA Tech Wabag Q2 Results FY27: Operating Profit Jumps 39.19% to Rs 124.30 Cr, PAT Rs 104.50 Cr

VA Tech Wabag Q2 Results FY27: Operating Profit Jumps 39.19% to Rs 124.30 Cr, PAT Rs 104.50 Cr


6 November 2026

12 min read

Pearl Global Industries Q2 Results FY27: Net Profit Jumps 74.74% to Rs 125.76 Cr, Revenue Rs 1,801.53 Cr

Pearl Global Industries Q2 Results FY27: Net Profit Jumps 74.74% to Rs 125.76 Cr, Revenue Rs 1,801.53 Cr


6 November 2026

13 min read

Astrazeneca Pharma India Q2 Results FY27: Revenue Jumps 30.41% to Rs 729.10 Cr, PAT Rs 62.33 Cr

Astrazeneca Pharma India Q2 Results FY27: Revenue Jumps 30.41% to Rs 729.10 Cr, PAT Rs 62.33 Cr


6 November 2026

13 min read

ad
Aadhar Housing Finance Q2 Results FY27: PAT Rises 15.69% to Rs 308.29 Cr, Revenue Rs 1,047.70 Cr, PAT Rs 308.29 Cr

Aadhar Housing Finance Q2 Results FY27: PAT Rises 15.69% to Rs 308.29 Cr, Revenue Rs 1,047.70 Cr, PAT Rs 308.29 Cr


6 November 2026

12 min read

Go Digit General Insurance Q2 Results FY27: PAT Falls 31.14% to Rs 142.39 Cr, Revenue Rs 2,720.49 Cr, PAT Rs 142.39 Cr

Go Digit General Insurance Q2 Results FY27: PAT Falls 31.14% to Rs 142.39 Cr, Revenue Rs 2,720.49 Cr, PAT Rs 142.39 Cr


6 November 2026

13 min read

ITD Cementation India Q2 Results FY27: PAT Rises 18.49% to Rs 127.57 Cr, Revenue Rs 2,682.65 Cr, PAT Rs 127.57 Cr

ITD Cementation India Q2 Results FY27: PAT Rises 18.49% to Rs 127.57 Cr, Revenue Rs 2,682.65 Cr, PAT Rs 127.57 Cr


6 November 2026

12 min read

Godfrey Phillips India Q2 Results FY27: PAT Falls 46.57% to Rs 162.98 Cr, Revenue Rs 4,202.44 Cr, PAT Rs 162.98 Cr

Godfrey Phillips India Q2 Results FY27: PAT Falls 46.57% to Rs 162.98 Cr, Revenue Rs 4,202.44 Cr, PAT Rs 162.98 Cr


6 November 2026

12 min read

ad
Astral Q2 Results FY27: Net Profit Rises 13.13% to Rs 152.50 Cr, Revenue Rs 1,772 Cr, PAT Rs 152.50 Cr

Astral Q2 Results FY27: Net Profit Rises 13.13% to Rs 152.50 Cr, Revenue Rs 1,772 Cr, PAT Rs 152.50 Cr


6 November 2026

12 min read

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

ad

FAQs

Yes, Univest owns SEBI-registered entities as its subsidiaries such as Uniresearch India Pvt. Ltd. SEBI-registered RA (INH00013776) and Univest Stock Broking Pvt. Ltd., a SEBI-registered stock broker (INZ000317437). Check the further details of registration on the official website. 

Univest offers trade ideas for stocks, futures, options, and commodities with the help of SEBI-registered research analysts. Univest performs AI-powered research to provide trade ideas with curated strategies and buy/sell/hold ratings for over 2,000 stocks. Investors may access the subscription plan to check their trade ideas for the duration of 1-month, 3-months, or 12-months.

Free trial of Univest is now available for new users who sign up for the first time. After sign up, user can avail 3 free trade ideas from highly skilled SEBI-registered research analysts. Visit the website now and sign up to get free trade ideas on Univest.

Univest maintains the confidentiality of user data by adhering to severe security measures and regulatory requirements. Sensitive details are encrypted with cutting-edge technology to avoid unauthorised access. The app abides by SEBI guidelines and data protection regulations in India, maintaining user confidence and transparency. Univest never shares personal or financial information with third parties without permission. Regular audits, secure servers, and AI-powered monitoring further enhance protection. Through these initiatives, Univest ensures that the investment process of each user is secure, confidential, and not subject to abuse of their personal details.

Univest stands out as a one-stop shop for investors looking for a research-based brokerage platform. It provides: 

  • Unbiased Stock Recommendations-Backed by SEBI-Reg. Experts.
  • Integration of Research and Execution Via Linked Demat Account.
  • Affordable Plans Starting Around ₹5 Per Day.
  • AI-Integrated Platform With Seamless Human Intervention.
  • Offers Real-Time Entry & Exit Signals During Market Hours.

The approach of Univest to research stock recommendations includes experienced SEBI-registered analysts with 75+ years of combined experience in leading the research procedure. Moreover, AI is being used to help screen and generate stock ideas, which are analysed and validated by seasoned analysts. The advisory part of Univest remains separate from the brokerage arm to eliminate the chances of conflicts of interest.

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down